News

The US Food and Drug Administration (FDA) has expanded the approval of ipilimumab (Yervoy) to include the treatment of pediatric melanoma patients 12 years and older with unresectable or metastatic disease.

Psoriatic arthritis can often go undiagnosed in patients with psoriasis, and an earlier diagnosis is critical to prevent the adverse effects of psoriatic arthritis, according to an expert.

Patients on Medicare who receive prescriptions for acne and rosacea from specialists pay more for those medications than they would from a primary care physician, according to results of a new study.

Adolescents who have acne may have higher grade point averages and higher earning potential in the job market, according to findings from a recent study.

In this month's Clinical Considerations, we take a look at biologics and treatments for seborrheic keratoses.

Up to 30% of pediatric primary care visits include a skin-related complaint, but the longstanding shortage of providers continues. One expert discusses some of the factors involved.

A pilot study has successfully challenged the current non-evidenced medical recommendation that patients with acne scars should wait six to 12 months after completion of oral isotretinoin treatment before the safe initiation of nonablative fractional laser resurfacing.

A nitric oxide-releasing gel to treat acne vulgaris has been found to be extremely safe, according to three Phase 1 pharmacokinetic clinical trials.

The approval of abatacept (Orencia/Bristol-Myers Squibb) for psoriatic arthritis (PsA) earlier this month by the FDA offers a new treatment option for patients who are struggling to keep the disease under control.

The Centers for Medicare and Medicaid Services (CMS) has notified more than 800,000 healthcare providers that they do not have to comply with the Merit-based Incentive Payment System in 2017.

Eric Schweiger, M.D., C.E.O., and founder of the Schweiger Dermatolo- gy Group, has been named a semifinalist for the EY Entrepreneur of the Year 2017 Award for the New York region, according to a news release.

Collaboration with specialists in other fields can improve outcomes for patients with skin cancer, and it can be personally and professionally rewarding for the dermatologist, according to one expert.

“Business literacy is an emerging competency that’s necessary for physicians,” says one dermatologist.

Dermatologists who plan to prescribe brodalumab may face a rough road.

It’s important that cosmetic dermatologists market to promote their practices. But, today, it’s vital they market to promote the common good - of the cosmetic medicine industry, that is.

Cosmetic practices have all the bells and whistles -from new technologies to skilled practitioners. So, why are so many competing on price?

The problem in the aesthetic marketplace is everyone offers the same thing, in the same way and says the same things, says one expert.

A new application of cyolipolysis proves to be an effective non-invasive option in the treatment of pseudogynecomastia, according to study.

Adalimumab (Humira, AbbVie) enhances both health-related quality of life and work productivity in patients with moderate-to-severe hidradenitis suppurativa, according to the results of two phase 3 clinical trials.

Long-term data for dupilumab in atopic dermatitis revealed at the American Academy of Dermatology (AAD) 75th Annual Meeting reflect safety, rapid relief of troublesome symptoms and a long-lived response in keeping with the drug’s breakthrough status, experts told Dermatology Times.

In our last article “Building a Patient Education Program” (May, page 82) we explored how a solid patient education program can keep patients, resources and revenue from falling through the cracks and what your practice needs to build a strong patient education program.

An old anti-aging concept was rediscovered with the renewed popularity of facial patches.

Korean facemasks are making their way from Asia to the US with great rapidity.

The digital beauty advisor is a digitized mirror providing personalized skin care information and day-to-day comparative health evaluations.

There are both unique nuances and cultural considerations to rejuvenating the skin of East Asian patients, according to one dermatologist.

The approval of dupilumab (Dupixent, Sanofi Regeneron) for moderate-to-severe atopic dermatitis adds a much-needed option that may alter the broader course of atopic disease, experts told Dermatology Times.

Dermatologists trying to boost practice revenue might add a device in hopes of making a profit on a cosmetic option or a skincare product line sold through the practice.

A laser is a suitable mode of treatment for certain dermatologic conditions in pediatric patients; however, there are certain procedural aspects that physicians should consider when treating younger children.

Castle Creek Pharmaceuticals announced in June 2017 that the first patient had enrolled in its phase 2/3 study assessing the safety and efficacy of its pipeline diacerein 1% ointment to treat epidermolysis bullosa simplex.

In July, our table of the month sums up biologics approved for moderate-to-severe plaque psoriasis and common adverse events associated with these biologics.